Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

A novel δ-protein-kinase inhibitor for adjunctive therapy during percutaneous coronary intervention

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 446–447 (2008)Cite this article

The DELTA MI Investigators (2008) Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation 117: 886–896

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Antman EM et al. (2008) 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 51: 210–247

    Article  Google Scholar 

  2. Silber S et al. (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26: 804–847

    Article  Google Scholar 

  3. Eagle KA et al. for the Global Registry of Acute Coronary Events (GRACE) Investigators (2008) Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 29: 609–617

    Article  Google Scholar 

  4. Svilaas T et al. (2008) Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 358: 557–567

    Article  CAS  Google Scholar 

  5. Van der Vleuten PA et al. (2008) The importance of left ventricular function in long-term prognosis after primary percutaneous coronary intervention. BMC Cardiovasc Disord 8: 4

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Thoraxcenter Department of Cardiology, University Medical Center, Groningen, PO Box 30 0001, Hanzeplein 1, Groningen 9700 RB, The Netherlands f.zijlstra@thorax.umcg.nl

Authors and Affiliations

  1. F Zijlstra is Director of the Thoraxcenter at the University Medical Center in Groningen, The Netherlands.,

    Felix Zijlstra

Authors
  1. Felix Zijlstra
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zijlstra, F. A novel δ-protein-kinase inhibitor for adjunctive therapy during percutaneous coronary intervention. Nat Rev Cardiol 5, 446–447 (2008). https://doi.org/10.1038/ncpcardio1269

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1269

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing